Covered recipient · General Payments record
JENNIFER L WOODWARD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2025
$9,836.24
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,038.75 | 5 |
| Travel and Lodging | $1,326.35 | 3 |
| Food and Beverage | $471.14 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $7,061.82 | 6 |
| Eli Lilly and Company | $2,625.00 | 3 |
| Amgen Inc. | $149.42 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $9,836.24 | 10 |
Payment records · PY2025 (10)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $149.42 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228444023 | CMS |
| Eli Lilly and Company | $1,875.00 | 03/11/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186700489 | CMS |
| Eli Lilly and Company | $375.00 | 04/25/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186655523 | CMS |
| Eli Lilly and Company | $375.00 | 12/17/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1186684551 | CMS |
| Novo Nordisk Inc | $828.36 | 08/07/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1188182190 | CMS |
| Novo Nordisk Inc | $355.00 | 08/07/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1188190890 | CMS |
| Novo Nordisk Inc | $330.50 | 08/07/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1188227546 | CMS |
| Novo Nordisk Inc | $167.49 | 08/07/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1188418931 | CMS |
| Novo Nordisk Inc | $321.72 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188490302 | CMS |
| Novo Nordisk Inc | $5,058.75 | 08/07/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1188515664 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.